Maiwei Biotech said its holding subsidiary Maiwei Vision has entered a strategic collaboration with ophthalmic small-molecule developer Weimou Biotech. The firms will undertake comprehensive, in-depth cooperation targeting unmet clinical needs in ocu

2026-06-17

Maiwei Biotech said its holding subsidiary Maiwei Vision has entered a strategic collaboration with ophthalmic small-molecule developer Weimou Biotech. The firms will undertake comprehensive, in-depth cooperation targeting unmet clinical needs in ocular inflammation and ocular immunity.